Showing results (1681-1690 of 2,298) with videos related to
Sort By:
Pageof 230
Clinical and Experimental Medicine|April 25, 2024
Infectious complications in pediatric patients undergoing CD19+CD22+ chimeric antigen receptor T-cell therapy for relapsed/refractory B-lymphoblastic leukemiaXiaochen Wu, Zhanmeng Cao, Zihan Chen, et al.Clinical and Experimental Medicine|April 29, 2024
High PPP4C expression predicts poor prognosis in diffuse large B-cell lymphomaXue Hui, Liru Li, Wenjing Xiong, et al.Clinical and Experimental Medicine|May 1, 2024
Inclusion body myositis, viral infections, and TDP-43: a narrative reviewVitalie Văcăraş, Romana Vulturar, Adina Chiş, et al.Clinical and Experimental Medicine|April 10, 2024
Antinuclear antibodies may predict the development of immune-related adverse events in asymptomatic patients treated with immune checkpoint inhibitors: results from a single-center cohortFulvia Ceccarelli, Francesco Natalucci, Licia Picciariello, et al.Clinical and Experimental Medicine|April 5, 2024
Letermovir prophylaxis for cytomegalovirus in lung-transplant recipients: a comprehensive study with literature review of off-label use and real-world experiencesTakashi Hirama, Yuki Shundo, Toshikazu Watanabe, et al.Clinical and Experimental Medicine|April 5, 2024
Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignanciesValentina Giudice, Monica Ianniello, Danilo De Novellis, et al.Clinical and Experimental Medicine|October 15, 2023
Subcutaneous panniculitis-like T-cell lymphoma associated with hemophagocytic lymphohistiocytosis: a systematic review of 63 patients reported in the literatureWenxin Ou, Yunze Zhao, Ang Wei, et al.Clinical and Experimental Medicine|October 27, 2023
COX5A as a potential biomarker for disease activity and organ damage in lupusMinglong Cai, Yi Qin, An Wan, et al.Clinical and Experimental Medicine|November 3, 2023
MicroRNA as a potential biomarker for systemic lupus erythematosus: pathogenesis and targeted therapyUrshila Naithani, Priyanjal Jain, Aastha Sachan, et al.Clinical and Experimental Medicine|November 2, 2023
Albumin-to-fibrinogen ratio is an independent prognostic parameter in de novo non-M3 acute myeloid leukemiaYaqun Ding, Xiangyu Qi, Yang Li, et al.Pageof 230